§ EQUITY
USD

RANI

RANI THERAPEUTICS HOLDINGS-A
USD
LAST
n/a
n/aPREV CLOSE · n/a
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX

§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY

13F FLOW
26 increased/new, 15 decreased/exited (13F)
AC 13F Analysis
§ 05 · WHO OWNS IT
Top institutional holders
All holders →
FundShares% portΔ Q/Q
SAMSARA BIOCAPITAL, LLC8.5M0.6%±0%
RA CAPITAL MANAGEMENT, L.P.8.5M0.1%±0%
AWM Investment Company, Inc.6.5M0.5%±0%
VANGUARD CAPITAL MANAGEMENT LLC4.6Mn/an/a
SymBiosis Capital Partners, LLC3.7M5.1%−42%
Longaeva Partners L.P.2.3M0.1%+10%
◇ AC INTELLIGENCE

Top institutional owners for RANI as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.

§ 06 · WHO OWNS IT · BY STRATEGY

OTHER88.2% · 55 holders
SYSTEMATIC / QUANT5.8% · 2 holders
PASSIVE / INDEX2.8% · 2 holders
DEALER / BANK1.6% · 12 holders
TACTICAL / MACRO1.6% · 4 holders
QUALITY / COMPOUNDER0.0% · 1 holder
◇ AC INTELLIGENCE

Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.

§ 07 · INSIDER ACTIVITY · LAST 180 DAYS

NO INSIDER FILINGS
◇ AC INTELLIGENCE

No Form 4 filings on record for RANI in the last 180 days.

§ 08 · COVERAGE · OUR RECENT NOTES